Ciaffoni Joseph 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Ciaffoni Joseph
Chief Operating Officer
Transactions
- Award
Common Stock
2024-02-12+119,000→ 394,000 total - Award
Common Stock
2024-02-12+179,734→ 573,734 total - Tax Payment
Common Stock
2024-02-12$33.70/sh−47,445$1,598,897→ 526,289 total - Tax Payment
Common Stock
2024-02-12$33.70/sh−81,422$2,743,921→ 444,867 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 179,734 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
- [F3]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
- [F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.